# Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness

> **NCT00214968** · PHASE3 · COMPLETED · sponsor: **Cephalon** · enrollment: 92 (actual)

## Conditions studied

- Narcolepsy

## Interventions

- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT00214968
- **Lead sponsor:** Cephalon
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2012-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00214968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00214968, "Assess the Safety and Effectiveness of PROVIGIL Treatment in Children and Adolescents With Excessive Sleepiness". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00214968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*